Repligen Corp.

NASDAQ:RGEN   3:15:13 PM EDT
177.59
+1.34 (+0.76%)
Products

Repligen And Navigo Proteins Announce Achievement In Developing An Affinity Resin For Purification Of COVID-19 Vaccines

Published: 10/01/2020 10:57 GMT
Repligen Corp (RGEN) - Repligen and Navigo Proteins Announce Achievement of Key Milestone in Developing an Affinity Resin for the Purification of Covid-19 Vaccines.
Repligen Corp - Repligen Anticipates That Final Resin Product Will Be Commercially Available in Early 2021.
Repligen Corp - Successful Development of an Affinity Ligand Targeting Spike Protein, to Be Utilized in Purification of Covid-19 Vaccines.